Cargando…

Antiplatelet therapy following TAVI: time to randomise

Detalles Bibliográficos
Autores principales: Delewi, R., Piek, J. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967555/
https://www.ncbi.nlm.nih.gov/pubmed/24399324
http://dx.doi.org/10.1007/s12471-013-0507-7
_version_ 1782309038793424896
author Delewi, R.
Piek, J. J.
author_facet Delewi, R.
Piek, J. J.
author_sort Delewi, R.
collection PubMed
description
format Online
Article
Text
id pubmed-3967555
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Bohn Stafleu van Loghum
record_format MEDLINE/PubMed
spelling pubmed-39675552014-03-27 Antiplatelet therapy following TAVI: time to randomise Delewi, R. Piek, J. J. Neth Heart J Editorial Comment Bohn Stafleu van Loghum 2014-01-08 2014-02 /pmc/articles/PMC3967555/ /pubmed/24399324 http://dx.doi.org/10.1007/s12471-013-0507-7 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by-nc/2.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Editorial Comment
Delewi, R.
Piek, J. J.
Antiplatelet therapy following TAVI: time to randomise
title Antiplatelet therapy following TAVI: time to randomise
title_full Antiplatelet therapy following TAVI: time to randomise
title_fullStr Antiplatelet therapy following TAVI: time to randomise
title_full_unstemmed Antiplatelet therapy following TAVI: time to randomise
title_short Antiplatelet therapy following TAVI: time to randomise
title_sort antiplatelet therapy following tavi: time to randomise
topic Editorial Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967555/
https://www.ncbi.nlm.nih.gov/pubmed/24399324
http://dx.doi.org/10.1007/s12471-013-0507-7
work_keys_str_mv AT delewir antiplatelettherapyfollowingtavitimetorandomise
AT piekjj antiplatelettherapyfollowingtavitimetorandomise